ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2598

Disease Characteristics Associated with the Presence of Dactylitis in Patients with EARLY Spondyloarthritis: Results from Esperenza Cohort

Maria Isabel Tévar Sánchez1, Victoria Navarro-Compán2, Raquel Almodóvar González3, Maria Pilar Fernández Dapica4, Pedro Zarco5 and Eugenio De Miguel6, 1Hospital Vega Baja, Orihuela, Alicante, Spain, 2Rheumatology, University Hospital La Paz, Madrid, Spain, 3Rheumatology Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain, 4University Hospital 12 de Octubre, Madrid, Spain, 5Rheumatology Department, Fundación Hospital Alcorcon, Alcorcon, Madrid, Spain, 6Department of Rheumatology, Hospital Universitario La Paz, Madrid, Spain

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: classification criteria and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment III

Session Type: Abstract Submissions (ACR)

Background/Purpose: Dactylitis is a typical manifestation in patients with SpA. Despite dactylitis has traditionally been related to the coexistence of psoriasis and peripheral arthritis, it was included as SpA feature for both (axial and peripheral) ASAS classification criteria. However, data supporting this is scarce, especially in patients with recent onset. The objective of this study was to determine the prevalence of dactylitis and which disease characteristics are associated with its presence in patients with early SpA.

Methods: Baseline dataset from the EsPeranza cohort (<45 years, symptoms duration 3-24 months and with inflammatory back pain -IBP- or asymmetrical arthritis or spinal/joint pain plus ≥1 SpA features) was analysed. For this study, 609 patients diagnosed of SpA by their physician were included. Logistic regression analysis was used to investigate the association between disease characteristics and the presence of dactylitis. These characteristics included family history of SpA, clinical manifestations (chronic back pain –CBP-, inflammatory back pain–IBP-, peripheral arthritis, enthesitis, uveitis, psoriasis, nail lesions, inflammatory bowel disease –IBD- and urethritis or cervicitis), activity parameters (SJC, physicianxs VAS, patientxs VAS and BASDAI), metrology (BASMI), function (BASFI), lab tests (HLA B27, ESR and CRP), and imaging (sacroiliitis on x-Ray or MRI by ASAS definition).

Results: Fifty eight (10.5%) patients had current or previous dactylitis. The presence of dactylitis was associated with peripheral arthritis, enthesitis, psoriasis, nail lesions, SJC, physicianxs VAS and CRP in the univariable analysis. Moreover, CBP, IBP and sacroiliitis were associated with absence of dactylitis. No significant differences were found for the rest of variables. In the multivariable analysis the presence of dactylitis was associated with peripheral arthritis, enthesitis, psoriasis and physicianxs VAS (Table). However, 14 (24%) patients did not have peripheral arthritis but had axial symptoms/signs.

Further, patients with dactylitis were classified as patients with dactylitis and psoriasis (n=19; 32.8%) and patients with dactylitis and no psoriasis (n=39; 67.2%). Disease characteristics were compared between both groups. Male were more frequent in the psoriasis group (84% vs 51%;p<0.05). The group without psoriasis had higher frequency of CBP, IBP, enthesitis, HLA-27 and sacroiliitis but these differences did not reach statistical significance.

Conclusion: Dactylitis is a frequent manifestation in patients with SpA even at early stages of the disease. Its presence is mainly associated with peripheral manifestations and psoriasis. However, the majority of patients with dactylitis do not have psoriasis and 24% of them have axial manifestations in absence of peripheral arthritis.

Table: Association between SpA characteristics and the presence of dactylitis

Characteristic

OR

95% CI

Chronic back pain

0.44

0.12 to 1.07

Inflammatory back pain

0.44

0.18 to 1.06

Peripheral arthritis

4.83 

2.00 to 11.7 

Enthesitis

2.49 

1.24 to 5.03 

Psoriasis

3.62 

1.63 to 8.04 

Nail lesions

0.61

0.12 to 3.18

Diarrhea, cervicitis, urethritis

2.17

0.54 to 8.77

CRP

0.99

0.97 to 1.01

ESR

1.01

0.99 to 1.03

Sacroiliitis

1.26

0.52 to 3.07

Physicianxs VAS

0.82 

0.70 to 0.96 


Disclosure:

M. I. Tévar Sánchez,
None;

V. Navarro-Compán,
None;

R. Almodóvar González,
None;

M. P. Fernández Dapica,
None;

P. Zarco,
None;

E. De Miguel,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/disease-characteristics-associated-with-the-presence-of-dactylitis-in-patients-with-early-spondyloarthritis-results-from-esperenza-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology